Royal Bank of Canada
RCKT icon

Royal Bank of Canada’s Rocket Pharmaceuticals RCKT Stock Holding History

Royal Bank of Canada’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-81,900
Closed -$1.4M – 7584
2023
Q1 		$1.4M Buy
+81,900
New +$1.6M ﹤0.01% 3082

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Royal Bank of Canada's RCKT Position: Q1 2026 in Review

Royal Bank of Canada reduced its Rocket Pharmaceuticals (RCKT) stake by 89% in Q1 2026, selling an estimated $10.2K and leaving 313 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #6933.

Royal Bank of Canada first reported a position in RCKT in Q3 2016 and has held it in 31 quarters since. The position peaked at $1.59M in Q1 2021. 199 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Royal Bank of Canada held 313 shares of Rocket Pharmaceuticals worth $1K as of Q1 2026.
  • Royal Bank of Canada sold 2,559 Rocket Pharmaceuticals shares in Q1 2026, an estimated $10.2K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6933 holding.
  • Royal Bank of Canada first reported a position in Rocket Pharmaceuticals in Q3 2016 and has held it in 31 quarters since.
  • Royal Bank of Canada's Rocket Pharmaceuticals position peaked at $1.59M in Q1 2021.
  • 199 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.